§ Funding Round
Series D funding round for PhaseBio Pharmaceuticals raising $34M in September 2018
Series D funding round for PhaseBio Pharmaceuticals raising $34M in September 2018
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Clay B. Thorp | — | — |
| Organization | — | |
| Organization | — | |
New Enterprise Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 8 funding rounds. Current round is highlighted.
Total Raised
$182.3M
Top Valuation
-
PhaseBio Pharmaceuticals raised $34M in a Series D round.
The round was announced on 09/01/18.
